Florida 2020 Regular Session Status: In Committee

HB 313 — Voluntary Registration of Stem Cell Providers

Last action — Died in Health and Human Services Committee

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed House
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill died with 2020 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.

This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.

Summary

Voluntary Registration of Stem Cell Providers; Authorizes licensed physicians who provide certain stem cell services & certain manufacturers & distributors of stems cells or stem cell products to register with DOH; requires such physicians to adhere to certain good manufacturing practices under federal laws; requires DOH to establish & maintain online registry identifying such physicians, manufacturers, & distributors & documenting physician agreements; requires DOH to update registry at least monthly.

Bill Text

What changed in the latest version

62 added · 145 removed

62 line(s) added, 145 removed.

→
Previous
Latest
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S HB 313 2020 A bill to be entitled An act relating to nonembryonic stem cells;
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S CS/HB 313 2020 A bill to be entitled An act relating to the voluntary registration of stem cell providers;
creating s.
defining the term "stem cell";
381.4017, F.S.;
authorizing a licensed physician who provides certain stem cell services to register with the Department of Health;
providing legislative findings and intent;
requiring that such physician agree to adhere to certain good manufacturing practices under specified federal laws;
providing definitions;
authorizing manufacturers and distributors of stem cells or products containing stem cells to register with the department;
authorizing the administration of nonembryonic stem cells and the use of such cells in health care products;
requiring the department to establish and maintain an online registry identifying such physicians, manufacturers, and distributors and documenting certain physician agreements;
authorizing the ownership and operation of a pharmacy in the state which compounds a drug, medicine, or health care product using nonembryonic stem cells;
requiring the department to update the information contained in the registry at least monthly;
authorizing the importation of any sterile compound, drug, or other treatment containing nonembryonic stem cells under certain circumstances;
authorizing the department to adopt rules;
authorizing certain licensed persons to administer or assist in the administration of such compounds, drugs, or other treatment;
authorizing the operation of stem cell banks in the state;
requiring a stem cell bank to register with the Department of Health;
providing requirements for a department-approved registration form;
requiring a stem cell bank to notify the department of any changes in information within a specified time period;
requiring a stem cell bank to obtain or otherwise carry professional liability insurance;
providing that a professional licensing board is not limited in its duties;
providing liability for persons who fail to use reasonable care;
requiring that the department Page 1 of 6 CODING:
Words stricken are deletions;
words underlined are additions.
hb0313-00 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S HB 313 2020 adopt by rule standards developed by an independent third party;
381.4017 Nonembryonic stem cells;
381.4017 Voluntary registration of stem cell providers.— (1) For purposes of this section, the term "stem cell" means an allogenic or autologous cell that is altered or Page 1 of 3 CODING:
stem cell bank registration.— (1) The Legislature finds that access to safe and high- quality health care services and products is of concern to all persons and regenerative medicine, including the use of nonembryonic stem cells, is a promising area of healthcare.
It is the intent of the Legislature to encourage and facilitate the safety of all health care services and products.
(2) As used in this section, the term:
(a) "Allogeneic" means originating from the body of another person.
(b) "Autologous" means originating from within a person's own body.
(c) "Department" means the Department of Health.
(d) "Independent third party" means an organization:
1.
That provides industry safety standards, relevant research, and an industry-specific database in association with one or more stem cell banks;
and Page 2 of 6 CODING:
hb0313-00 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S HB 313 2020 2.
hb0313-01-c1 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S CS/HB 313 2020 processed to become undifferentiated, losing its original structural function, so that it can become differentiated into a specialized cell type.
Whose members are registered with the department.
The term does not include cells that are only rinsed, cleaned, or sized and remain differentiated.
(e) "Nonembryonic stem cells" means autologous or allogeneic cellular material that:
(2) A physician licensed under chapter 458 or chapter 459 who advertises, uses, or purports to use stem cells or products containing stem cells may register with the department.
1.
A physician who registers under this section shall agree to adhere to the current applicable good manufacturing practices for the collection, removal, processing, implantation, and transfer of stem cells, or products containing stem cells, pursuant to the Federal Food, Drug, and Cosmetic Act, 21 U.S.C.
Has not been isolated or obtained directly from human embryos;
ss.
and 2.
301 et seq.;
May have been or may be combined with one or more:
52 Stat.
a.
1040 et seq.;
Naturally occurring biomaterials;
and 21 C.F.R.
Show all 81 changed rows (41 more)
Previous
Latest
or b.
1271, Human Cells, Tissues, and Cellular and Tissue-Based Products, in the performance of any procedure using or purporting to use stem cells or products containing stem cells.
Materials approved or cleared by the United States Food and Drug Administration or other applicable agency or authority.
(3) A manufacturer or distributor of stem cells or products containing stem cells who advertises, distributes, or operates in this state may register with the department.
(f) "Stem cell bank" means a facility that stores nonembryonic stem cells.
(4) The department shall establish and maintain an online registry accessible on its website which identifies the physicians, manufacturers, and distributors registered under this section and which documents physician agreements to adhere to the current applicable good manufacturing practices.
(3) Nonembryonic stem cells may be administered to a person by:
The department shall update the information contained in the Page 2 of 3 CODING:
(a) Himself or herself;
or (b) A person licensed or authorized in this state to administer or assist in the administration of medicine or health care if such person administers or assists in the administration of the nonembryonic stem cells using a mode of administration permitted under his or her license or authorization.
(4) A health care product may be compounded using nonembryonic stem cells as a sterile ingredient either by themselves or in combination with other sterile ingredients.
A pharmacy that compounds a drug, medicine, or health care product using nonembryonic stem cells may be owned or operated, or both, in this state.
Page 3 of 6 CODING:
hb0313-00 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S HB 313 2020 (5)(a) A person may import into this state any sterile compound, drug, or other treatment containing nonembryonic stem cells if such compound, drug, or other treatment:
hb0313-01-c1 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S CS/HB 313 2020 registry at least monthly.
1.
(5) The department may adopt rules to implement this section.
Was obtained without violating the laws of the jurisdiction in which it was obtained;
and 2.
Is for personal use.
(b) A person licensed or authorized in this state to administer or assist in the administration of medicine or health care may administer or assist in the administration of the imported sterile compound, drug, or other treatment containing nonembryonic stem cells if such person administers or assists in the administration of such compound, drug, or other treatment using a mode of administration permitted under his or her license or authorization.
(6)(a) Notwithstanding any other provision of law, a stem cell bank may operate in this state.
(b) Before organizing or arranging for the operation of a stem cell bank in this state, a stem cell bank must register with the department by submitting a department-approved registration form that contains:
1.
The name, street address, and telephone number of the stem cell bank.
2.
The name, street address, and telephone number of each officer, director, or organizational official of the stem cell bank who is responsible for the operation of the stem cell bank.
Page 4 of 6 CODING:
Words stricken are deletions;
words underlined are additions.
hb0313-00 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S HB 313 2020 3.
Identification of the types of human tissue used in business or research at the stem cell bank.
4.
Identification of the product names produced at the stem cell bank for distribution.
5.
Any other information required for registration by the department.
(c) Each stem cell bank shall notify the department in writing of any change in the information required for registration not later than 10 days after such change goes into effect.
(d) Each stem cell bank that operates in this state must obtain or otherwise carry, before engaging in such business, a policy of professional liability insurance that insures the stem cell bank against any liability arising from the operation of such business.
(7) This section does not absolve:
(a) A professional licensing board of the duty to regulate licenses or otherwise prohibit or limit the powers and duties of a licensing board to regulate the procedures used to administer nonembryonic stem cells.
(b) Any person of civil or criminal liability or penalty for failure to use the reasonable care, skill, or knowledge ordinarily used in rendering health care services or administering health care products under similar circumstances.
(8) The department shall adopt by rule standards developed Page 5 of 6 CODING:
Words stricken are deletions;
words underlined are additions.
hb0313-00 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S HB 313 2020 by an independent third party to ensure public safety and to implement this section.
Page 6 of 6 CODING:
Page 3 of 3 CODING:
hb0313-00
hb0313-01-c1
View plain text versions (2)

Action History

  1. Died in Health and Human Services Committee

  2. Indefinitely postponed and withdrawn from consideration

  3. Now in Health and Human Services Committee

  4. Favorable by Health Care Appropriations Subcommittee; YEAS 10 NAYS 0

  5. On Committee agenda-- Health Care Appropriations Subcommittee, 02/11/20, 1:30 pm, Reed Hall

  6. Now in Health Care Appropriations Subcommittee

  7. CS by Health Quality Subcommittee read 1st time

  8. Pending review of CS under Rule 7.18(c)

  9. CS by Health Quality Subcommittee; YEAS 12 NAYS 0

  10. PCS on Committee agenda-- Health Quality Subcommittee, 02/03/20, 3:00 pm, Webster Hall

  11. Introduced

  12. Referred to Health Quality Subcommittee; Health Care Appropriations Subcommittee; Health and Human Services Committee

  13. Filed

Sponsors

  • Health Quality Subcommittee · Primary

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 0 co-sponsors · 163 not signed on

Sponsors (1)

  • Health Quality Subcommittee

Co-sponsors (0)

None.

Not signed on (163)

163 members have not signed on to this bill.

Show all 163 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Votes

Passed 10 Yea · 0 Nay · 2 Other
Party YeaNayPresentNot Voting
Unaffiliated 8001
Republican 2000
Democrat 0001
Total 10002
% of votes cast 83%0%0%17%
How each member voted (12)
Member Party Vote
Ausley — Yea
Duran — Yea
Grant, J. — Not Voting
Grieco — Yea
Magar — Yea
Pigman — Yea
Roach — Yea
Rommel — Yea
Stevenson — Yea
Jones, Shevrin D. "Shev" Democrat Not Voting
Burton, Colleen Republican Yea
Rodriguez, Ana Maria Republican Yea

Official roll call →

Passed 12 Yea · 0 Nay · 3 Other
Party YeaNayPresentNot Voting
Unaffiliated 4001
Republican 5002
Democrat 3000
Total 12003
% of votes cast 80%0%0%20%
How each member voted (15)
Member Party Vote
Bell — Yea
Beltran — Yea
Brown — Not Voting
Mariano — Yea
Sullivan — Yea
Daniels, Kimberly Democrat Yea
Davis, Tracie Democrat Yea
Smith, Carlos Guillermo Democrat Yea
Burton, Colleen Republican Yea
Maggard, Randall Scott "Randy" Republican Yea
Plasencia, Susan Republican Not Voting
Rodriguez, Ana Maria Republican Yea
Shoaf, Jason Republican Yea
Stark, Paula A. Republican Yea
Yarborough, Clay Republican Not Voting

Official roll call →

Subjects

Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does HB 313 do?
Voluntary Registration of Stem Cell Providers; Authorizes licensed physicians who provide certain stem cell services & certain manufacturers & distributors of stems cells or stem cell products to register with DOH; requires such physicians to adhere to certain good manufacturing practices under federal laws; requires DOH to establish & maintain online registry identifying such physicians, manufacturers, & distributors & documenting physician agreements; requires DOH to update registry at least monthly.
Who sponsors HB 313?
HB 313 is sponsored by Health Quality Subcommittee.
What is the current status of HB 313?
This bill died with 2020 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
Where can I track HB 313?
Track HB 313 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HB 313

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Stay ahead of HB 313

Last checked for changes 2 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →